Patricia Zettler

[1] Hutt PB, Merrill RA, Grossman LA, Cortez N, Lietzan E, Zettler PJ. Food and Drug Law: Cases and Materials, Fifth Edition. Foundation
Press, forthcoming July 2022.

[2] Zettler PJ, Guerrini CJ, Sherkow JS. Regulating genetic biohacking. Science. 2019 Jul 5;365(6448):34-36, https://www.science.org/doi/10.1126/science.aax3248

[3] Lynch HF, Sarpatwari A, Vonderheide R, Zettler PJ. Right to Try Requests and Oncologists’ Gatekeeping Obligations. Journal of Clinical Oncology (2019), https://ascopubs.org/doi/10.1200/JCO.19.01741

[4] Lynch HF, Zettler PJ, Sarpatwari A. Promoting Patient Interests in Implementing the Federal Right to Try Act. JAMA. 320(9):869-870 (2018), doi:10.1001/jama.2018.9880 

[5] Sherkow JS, Zettler PJ, Greely HT, Is it ‘gene therapy’?, Journal of Law and the Biosciences, Volume 5, Issue 3, December 2018, Pages 786–793, https://doi.org/10.1093/jlb/lsy020

[6] Zettler PJ, Compassionate Use of Experimental Medicines: Who Should Decide?, EMBO Molecular Medicine, 7(10): 1248–1250 (2015), https://www.embopress.org/doi/full/10.15252/emmm.201505262.